Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended pre-quit varenicline use and post-quit smoking urges
2008-004720-24Phase 4Completed
- Sponsor
- Queen Mary University of London
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of varenicline in nicotine dependence (2 arms), sponsored by Queen Mary University of London. Primary endpoints: Post-quitting urges to smoke at 24 hours and Post-quitting urges to smoke at 1 week. Started Apr 2009; status: completed.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on 2008-004720-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004720-24.